Kirkland Represents Altaris on Combination of Kindeva Drug Delivery and Meridian Medical Technologies and Financing of Combined Company

Kirkland & Ellis advised Altaris, LLC, a healthcare investment firm, on the combination of two of its operating companies, Kindeva Drug Delivery and Meridian Medical Technologies, and the financing of the combined company. The combination will create a leading global drug-device combination product Contract Development and Manufacturing Organization. Financing for the transaction is being arranged by JP Morgan Chase Bank, N.A., Truist Securities, Inc. and Keybanc Capital Markets Inc.

Read the transaction press release

The Kirkland team for the combination was led by corporate partners David Feirstein and Michael Amalfe and associates Megha Vyas and Eddie Nwaba. The Kirkland team for the financing was led by debt finance partners Jason Kanner and Whitney Bosworth and associate Kelsey Fuller. The combined team was also led by investment funds partner Sean Malone, executive compensation partners Scott Price and David Branham, tax partner Sara Zablotney, international trade partners Ivan Schlager and Nathan Mitchell, and antitrust & competition partners Mark Gardner and Andrea Murino.